Technologies related to NHGRI

Non-invasive Pan-Cancer Detection Method
Ref: E-177-2015/0 | Updated: Nov 8, 2016
Tagged Form of Mut Enzyme and Its Use in Gene Therapy
Ref: E-090-2015/0 | Updated: Apr 18, 2016
Gene Therapy for Niemann-Pick Disease Type C
Ref: E-185-2014/0 | Updated: Apr 18, 2016
Novel Codon-Optimized Gene Therapeutic for Methylmalonic Acidemia
Ref: E-243-2012/0 | Updated: Oct 27, 2014
Use of Small Molecules to Treat PARP1-deficient Cancers
Ref: E-039-2014/0 | Updated: Dec 16, 2015
Mouse Model for Methylmalonic Acidemia, an Inherited Metabolic Disorder
Ref: E-285-2011/1 | Updated: Dec 3, 2013
Blood-Based Assay for the Diagnosis and Monitoring of Hyposialylation Disorders
Ref: E-056-2013/0 | Updated: Sep 14, 2017
Human Melanoma Metastasis Cell Lines Harboring Bcl-2-Like Protein 12 (BCL2L12) Mutations
Ref: E-145-2012-0 | Updated: May 8, 2018
Predicting Age of Onset of Niemann-Pick Disease
Ref: E-060-2013/0 | Updated: Jun 21, 2013
Human Melanoma Metastasis Cell Lines Harboring GRM3 Mutations
Ref: E-029-2012-0 | Updated: May 8, 2018
Human Melanoma Metastasis Cell Lines Harboring MITF Mutations
Ref: E-023-2012-0 | Updated: May 8, 2018
Human Melanoma Metastasis Cell Lines Harboring TRRAP, GRIN2A, and PLCB4 Mutations
Ref: E-024-2012-0 | Updated: May 8, 2018
Mutations in the G Protein Coupled Receptor (GPCR) Gene Family in Melanoma
Ref: E-244-2010-0 | Updated: May 8, 2018
Glucocerebrosidase Non-inhibitory Chaperones for the Treatment of Gaucher Disease, Parkinson's Disease, and Other Proteinopathies
Ref: E-144-2012-0 | Updated: May 1, 2018
Zuma Mutant Mice as a Tool for Investigating Mammalian Developmental Defects
Ref: E-294-2012/0 | Updated: Oct 22, 2012
New Targeted Therapy for Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
Ref: E-060-2011/0 | Updated: Sep 10, 2012
Human Renal Epithelial Tubular Cells for Studies of Cystinosis
Ref: E-204-2012/0 | Updated: Sep 21, 2015
Model Cell Lines With and Without AKT1 Mutations Derived from Proteus Syndrome Patients
Ref: E-033-2012/0 | Updated: Oct 13, 2015
Antagonists of the Hedgehog Pathway as Treatment of Heterotopic Ossification, Vascular Calcification, and Pathologic Mineralization
Ref: E-116-2011-0 | Updated: May 7, 2018
Encapsulated N-Acetylmannosamine or N-Acetylneuraminic Acid as a Therapeutic Agent for Increasing Sialylation in Certain Muscular Atrophies, Kidney Disorders, Cancers or Poor Immune Function
Ref: E-270-2011/0 | Updated: Sep 21, 2015
TRRAP and GRIN2A Mutations for the Diagnosis and Treatment of Melanoma
Ref: E-013-2011-0 | Updated: May 8, 2018
Isocitrate Dehydrogenase 1 (IDH1) R132 Mutation Human Melanoma Metastasis Cell Line
Ref: E-232-2010-0 | Updated: May 8, 2018
ERBB4 Mutations Identified in Human Melanoma Metastasis Cell Lines (2690, 2379, 2197, 2183, 2535, 2645, 1770, 2359, 2238, 2319, 2190)
Ref: E-229-2010-0 | Updated: May 8, 2018
Use of Adenosine Agonists to Prevent Arterial Vascular Calcification Disorder
Ref: E-094-2010/0 | Updated: Mar 18, 2015
Mutations of the ERBB4 Gene in Melanoma
Ref: E-272-2008-0 | Updated: May 8, 2018
Device and Method for Direct Measurement of Isotopes of Expired Gases: Application in Research of Metabolism and Metabolic Disorders, and in Medical Screening and Diagnostics
Ref: E-099-2009/0 | Updated: Jul 5, 2012
C57BL/6J Embryonic Stem Cell Lines Generated Using Serum-Free Media
Ref: E-038-2009/0 | Updated: May 15, 2009
A Parameterized Model for Simulating Microarrays
Ref: E-089-2003/0 | Updated: Feb 2, 2009
Fluorescent Cell Lines for Detection of DNA Damage
Ref: E-108-2008/0 | Updated: Aug 1, 2008
N-Acetyl Mannosamine as a Therapeutic Agent
Ref: E-217-2007/0 | Updated: Sep 23, 2015
Viral Entry or Replication Inhibitors
Ref: E-151-2006/0 | Updated: Jun 14, 2010
Methods and Materials for Identifying Polymorphic Variants, Diagnosing Susceptibilities, and Treating Disease
Ref: E-149-2005/0 | Updated: Jul 1, 2007
Genetic Markers for Body Size in Dogs
Ref: E-009-2007/0 | Updated: Apr 1, 2007
Monoclonal Antibody to the Protein NCOA6 (also called ASC-2, AIB-3)
Ref: E-168-2005/0 | Updated: Aug 1, 2005
Farnesyltransferase Inhibitors for Treatment of Laminopathies, Cellular Aging and Atherosclerosis
Ref: E-055-2005/2 | Updated: Sep 24, 2015
Methods for Analyzing High Dimensional Data for Classifying, Diagnosing, Prognosticating, and/or Predicting Diseases and Other Biological States
Ref: E-324-2001/0 | Updated: Feb 1, 2005
Selections of Genes
Ref: E-324-2001/1 | Updated: Feb 1, 2005
Rapid Integration Site Mapping
Ref: E-027-2004/0 | Updated: May 1, 2004
SAP/SH2D1A Knockout Mice: A Model for X-linked Lymphoproliferative Disease
Ref: E-343-2003/0 | Updated: Jun 16, 2010
Methods for Detecting Cancer Cells
Ref: E-211-1998/0 | Updated: Dec 1, 2003
Tec Kinase Deficient Mice
Ref: E-178-2003-0 | Updated: May 10, 2018
LMNA Gene and Its Involvement in Hutchinson-Gilford Progeria Syndrome and Arteriosclerosis
Ref: E-020-2003/1 | Updated: Oct 5, 2015
Use of Interferon-Inducible 2',5'-Oligoadenylate-Dependent RNase in the Diagnosis, Prognosis, and Treatment of Prostate Cancer
Ref: E-196-2001/0 | Updated: Nov 1, 2002
A Mouse Model of Multiple Endocrine Neoplasia, Type I
Ref: E-243-2001/0 | Updated: Mar 10, 2014
Transgenomic Viruses
Ref: E-011-1997/0 | Updated: Jun 1, 1999
Tissue Microarray For Rapid Molecular Profiling
Ref: E-007-1999/0 | Updated: Jan 1, 1999
Tumor Tissue Microarrays For Rapid Molecular Profiling
Ref: E-002-1998/0 | Updated: May 16, 2016
AIB-1, A Steroid Receptor Co-Activator Amplified In Breast And Ovarian Cancer
Ref: E-018-1997/0 | Updated: May 16, 2016
Transgenic And Chimeric Viral Delivery Systems
Ref: E-011-1997/0 | Updated: Aug 1, 1997
MEN1, The Gene For Multiple Endocrine Neoplasia Type 1
Ref: E-094-1997/0 | Updated: Aug 1, 1997
Subscribe to Technologies related to NHGRI